Imaging in Women with Heart Failure: Sex-specific Characteristics and Current Challenges

Overview

Journal Card Fail Rev

Date 2022 Oct 28

PMID 36303591

Authors

Isabella Leo

Eleni Nakou

Antonio de Marvao

Joyce Wong

Chiara Bucciarelli-Ducci

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) represents a significant threat to women's health. Heart failure (HF) is one CVD that still has an increasing incidence and about half of all cases involve women. HF is characterised by strong sex-specific features in aetiology, clinical manifestation and outcomes. Women are more likely to have hypertensive heart disease and HF with preserved ejection fraction, they experience worse quality of life but have a better overall survival rate. Women's hearts also have unique morphological characteristics that should be considered during cardiovascular assessment. It is important to understand and highlight these sex-specific features to be able to provide a tailored diagnostic approach and therapeutic management. The aim of this article is to review these aspects together with the challenges and the unique characteristics of different imaging modalities used for the diagnosis and follow-up of women with HF.

Citing Articles

Feasibility and Role of Cardiac Magnetic Resonance in Intensive and Acute Cardiovascular Care.

Leo I, Figliozzi S, Ielapi J, Sicilia F, Torella D, Dellegrottaglie S J Clin Med. 2025; 14(4).

PMID: 40004642 PMC: 11856486. DOI: 10.3390/jcm14041112.

Intracardiac fluid dynamic analysis: available techniques and novel clinical applications.

Leo I, Cersosimo A, Ielapi J, Sabatino J, Sicilia F, Strangio A BMC Cardiovasc Disord. 2024; 24(1):716.

PMID: 39702022 PMC: 11660877. DOI: 10.1186/s12872-024-04371-3.

Imaging and Heart Failure: What the Future Holds?.

Di Maio S, Thamman R, Grapsa J Card Fail Rev. 2024; 10:e16.

PMID: 39649815 PMC: 11622218. DOI: 10.15420/cfr.2023.11.

Peripartum cardiomyopathy: a comprehensive and contemporary review.

Sigauke F, Ntsinjana H, Tsabedze N Heart Fail Rev. 2024; 29(6):1261-1278.

PMID: 39348083 PMC: 11455798. DOI: 10.1007/s10741-024-10435-5.

Complex Connections: Myocardial Fibrosis, Reproductive Factors, and Heart Failure.

Panjrath G, Choi A JACC Adv. 2024; 2(10):100698.

PMID: 38938492 PMC: 11198301. DOI: 10.1016/j.jacadv.2023.100698.

References

Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P . Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013; 108(4):366. PMC: 3709080. DOI: 10.1007/s00395-013-0366-9. View

Doyle M, Weinberg N, Pohost G, Merz C, Shaw L, Sopko G . Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Imaging. 2010; 3(10):1030-6. PMC: 3278772. DOI: 10.1016/j.jcmg.2010.07.008. View

Adamo M, Lombardi C, Metra M . May 2020 at a glance: ischaemic heart failure and sex-related differences. Eur J Heart Fail. 2020; 22(5):761-762. DOI: 10.1002/ejhf.1513. View

Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J . Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005; 52(12):3792-800. DOI: 10.1002/art.21433. View

Galie N, Hinderliter A, Torbicki A, Fourme T, Simonneau G, Pulido T . Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003; 41(8):1380-6. DOI: 10.1016/s0735-1097(03)00121-9. View

Gulati A, Ismail T, Jabbour A, Ismail N, Morarji K, Ali A . Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2013; 15(6):660-70. DOI: 10.1093/eurjhf/hft019. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129(3):399-410. DOI: 10.1161/01.cir.0000442015.53336.12. View

Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G . Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging. 2014; 15(6):680-90. PMC: 4402333. DOI: 10.1093/ehjci/jet284. View

. Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017; 130(4):e210-e216. DOI: 10.1097/AOG.0000000000002355. View

10.

Mavrogeni S, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Bounas A, Tektonidou M, Lliossis S . Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus. Lupus. 2017; 27(4):564-571. DOI: 10.1177/0961203317731533. View

11.

Ware J, Li J, Mazaika E, Yasso C, DeSouza T, Cappola T . Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016; 374(3):233-41. PMC: 4797319. DOI: 10.1056/NEJMoa1505517. View

12.

Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral F, Cobo-Marcos M, Robles C . Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015; 36(38):2585-94. DOI: 10.1093/eurheartj/ehv338. View

13.

Petersen S, Khanji M, Plein S, Lancellotti P, Bucciarelli-Ducci C . European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging. 2019; 20(12):1321-1331. DOI: 10.1093/ehjci/jez232. View

14.

Nadjiri J, Hausleiter J, Jahnichen C, Will A, Hendrich E, Martinoff S . Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up. J Cardiovasc Comput Tomogr. 2016; 10(2):97-104. DOI: 10.1016/j.jcct.2016.01.007. View

15.

Dewan P, Rorth R, Jhund P, Shen L, Raparelli V, Petrie M . Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women. J Am Coll Cardiol. 2019; 73(1):29-40. DOI: 10.1016/j.jacc.2018.09.081. View

16.

Garceau P, Nguyen E, Carasso S, Ross H, Pendergrast J, Moravsky G . Quantification of myocardial iron deposition by two-dimensional speckle tracking in patients with β-thalassaemia major and Blackfan-Diamond anaemia. Heart. 2011; 97(5):388-93. DOI: 10.1136/hrt.2010.192641. View

17.

Gan C, Holverda S, Marcus J, Paulus W, Marques K, Bronzwaer J . Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest. 2007; 132(1):11-7. DOI: 10.1378/chest.06-1263. View

18.

Howard L, Grapsa J, Dawson D, Bellamy M, Chambers J, Masani N . Echocardiographic assessment of pulmonary hypertension: standard operating procedure. Eur Respir Rev. 2012; 21(125):239-48. PMC: 9487330. DOI: 10.1183/09059180.00003912. View

19.

Bohm M, Cammann V, Ghadri J, Ukena C, Gili S, Di Vece D . Interaction of systolic blood pressure and resting heart rate with clinical outcomes in takotsubo syndrome: insights from the International Takotsubo Registry. Eur J Heart Fail. 2018; 20(6):1021-1030. DOI: 10.1002/ejhf.1162. View

20.

Briasoulis A, Mocanu M, Marinescu K, Qaqi O, Palla M, Telila T . Longitudinal systolic strain profiles and outcomes in peripartum cardiomyopathy. Echocardiography. 2016; 33(9):1354-60. DOI: 10.1111/echo.13277. View